Metabolic reprogramming is recognized as a significant driver of tumor development, exemplified by the Warburg effect, which results in the production of excess lactate, citrate, and glycerol, subsequently contributing to de novo lipid synthesis through acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). Here, FAS is linked to neoplasm.